Healthpeak Properties ($DOC) – What Does the Company Do? Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Summary
Healthpeak Properties (DOC) is a healthcare REIT that owns and leases life-science research facilities, medical office buildings, and senior living residences. Rising demand for healthcare and research driven by population aging, rental stability supported by high tenant switching costs, and a consistent dividend are cited as the core pillars of its earnings and stock outlook.
🏢 What kind of company is Healthpeak Properties?
Healthpeak Properties (DOC) is a healthcare real estate investment trust (REIT) that owns and leases medical-related properties such as hospitals, research facilities, and medical offices. It leases research facilities to pharmaceutical and biotech companies and medical offices used by physicians and hospitals, generating rental revenue.
Its business is divided into the leasing of healthcare-related properties, including life-science research facilities, medical office buildings, and senior living residences. Research facilities leased to pharmaceutical and biotech companies and medical offices near hospitals are the core assets, and the company earns stable rental income under long-term lease contracts on the structural foundation of medical demand. Under its REIT structure, a substantial portion of earnings is returned to shareholders as dividends.
How does Healthpeak Properties make money?| Business Segment | Revenue Mix | Description |
|---|---|---|
| Life-science research facilities | Core | Research facilities leased to pharmaceutical and biotech companies; the largest segment by rental share |
| Medical office buildings | Expanding | Stable segment that leases medical offices near hospitals and clinics |
| Senior living & others | Diversification driver | Healthcare-related properties such as senior living facilities |
The majority of Healthpeak Properties' revenue comes from leasing life-science research facilities and medical office buildings. Healthcare and research demand is less sensitive to economic cycles and is structurally growing, keeping rental rates and occupancy relatively stable. In particular, pharmaceutical and biotech research facilities require specialized equipment, which makes tenant switching costs high. The company expanded its scale through a merger with a medical office REIT and pays steady dividends under its REIT structure on the back of stable rental cash flow.
📐 Healthpeak Properties market cap and company size
Its market cap stands at $15.6B, and the number of 411명 is not publicly disclosed.
It is one of the largest REITs in the U.S. healthcare real estate market, with a broad healthcare property portfolio centered on life-science research facilities and medical office buildings. It generates stable rental income on the structural foundation of medical demand and high tenant switching costs, and has strengthened its scale and diversification through mergers.
📈 Healthpeak Properties outlook and stock-price trends
Expanding healthcare real estate demand driven by population aging and growing medical and research needs is the medium- to long-term engine. Life-science research facilities and medical office buildings generate stable rental income on a structurally supportive demand base. The company pursues growth through merger synergies and the expansion of development and leasing. However, rising interest rates can pressure REIT valuations and interest expense, new supply and softer leasing demand in the life-science segment, and the financial condition of some tenants can act as short-term variables on earnings.
- Population aging and growing medical and research demand
- Stable leasing of life-science research facilities and medical office buildings
- Merger synergies and expansion of development and leasing
⚔️ Healthpeak Properties core strengths and risks
Stable rental income backed by healthcare demand, high tenant switching costs, and a consistent dividend are its strengths, while interest-rate sensitivity and life-science supply and demand variables are its key risks.
💪 Core Strengths
⚠️ Key Risks
🔄 Healthpeak Properties competitors and related (beneficiary) stocks
Within healthcare real estate, Healthpeak Properties is directly compared with other healthcare REITs. Senior living and medical facility operators such as WELL and VTR, along with life-science research facility-focused ARE, are cited as similar peers in terms of business structure and tenant mix.
| 종목 | 회사명 | 가격 | 등락 | 시총 | PER | PBR | ROE | 배당률 |
|---|---|---|---|---|---|---|---|---|
| WELL | Welltower Inc | $235.63 | -2.3% | $169.8B | - | 3.6 | 3.77% | 1.34% |
| VTR | Ventas Inc | $91.92 | -5.9% | $45.7B | 168.6 | 3.2 | 2.01% | 2.26% |
| Alexandria Real Estate Equities Inc | $52.49 | -2.4% | $9.1B | - | 0.6 | -6.43% | 5.49% |
✅ Healthpeak Properties investor checklist
Healthpeak Properties is a healthcare REIT that owns and leases life-science research facilities, medical office buildings, and senior living residences, offering attractive stable rental income backed by medical demand and a consistent dividend, but investors should also monitor interest-rate sensitivity and life-science supply-demand variables.
| Checklist | What to review | Current status |
|---|---|---|
| 🔬 Life-science leasing | Rental rates, occupancy, and new supply for research facilities | Supply and demand monitoring |
| 🏥 Medical offices | Leasing stability of medical office buildings | Defensive base |
| 💰 Dividend & rates | Dividend trajectory and interest expense driven by rates | Rate-sensitive |
Valuation and interest expense pressure from rising rates, alongside new supply and softer leasing demand in life-science research facilities, and the financial condition of some tenants, can affect earnings and dividend capacity, so it is necessary to examine leasing stability and life-science supply-demand together.
Healthpeak Properties is a healthcare REIT with stable rental income backed by medical demand, high tenant switching costs, and a consistent dividend, but given interest-rate sensitivity and life-science supply-demand variables, a medium- to long-term approach is advisable.
이 글은 2026년 6월 4일 기준 정보입니다.